Convexity Labs

ASUR

Convexity Analyst · ASUR
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ASUR (Asure Software, Inc.) Analyst Note Date: 2026-06-13 Current Price: $8.27

1. Structural Readiness

State: Context-Only / Forming Aggressive/Pre-Breakout Entry: N/A (Current price is $8.27; no specific breakout level defined in source data) Breakout Level: Pending confirmation. Extension: Not applicable (Price has not yet broken out). Current Price: $8.27 ATR Current: 6.4% (Very High)

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED Macro Thesis: None named at this date. Assessment: This is a tactical, setup-led name. There is no named secular thesis driving the conviction at this specific point in time. The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals (revenue growth, margin expansion, and backlog health) as reported by management. Do not invent a macro narrative; the thesis is the convergence of a structural breakout setup with a company demonstrating accelerating organic growth and path to profitability.

3. The Business

Company Overview: Asure Software, Inc. is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes, with a specific focus on small and mid-sized businesses (SMBs) in payroll-intensive, compliance-driven industries. The company serves over 100,000 clients across the United States.

Business Model & Operations:

  • Core Platform: The Asure HCM platform is a SaaS-based system integrating Payroll & Tax filing, HR management, Time & Attendance, Recruiting, and Benefits Administration.
  • Revenue Drivers: Recurring revenue is driven by fees for application usage and per-employee charges for check/report delivery. Consequently, recurring revenue scales with client headcount growth.
  • Distribution: Approximately 35% of clients are direct, while the remaining 65% are acquired through Reseller Partners who white-label Asure's solutions.
  • Service Layer: Beyond software, Asure provides HR services including compliance updates, strategic decision support, and full HR outsourcing.

Financial & Operational Evidence (as of 2026-06-13):

  • Revenue Growth: Q1 2026 revenue was $42.8 million, representing 23% year-over-year growth compared to Q1 2025.
  • Organic Growth: Organic growth rate for Q1 2026 was 7%, a significant acceleration from 3% in Q1 2025 and 3.5% in Q1 2024.
  • Backlog Health: Contracted backlog stands at approximately $85.6 million. Management expects to convert approximately 38% of this backlog over the next 12 months.
  • Recurring Revenue: Recurring revenue for the three months ended March 31, 2026, was $37.76 million, an increase of 14% year-over-year.
  • Profitability Turnaround: The company generated income of $0.02 per share in Q1 2026, a marked improvement from a loss of $0.09 per share in Q1 2025.
  • Guidance: Management expects full-year 2026 revenue of $159 million to $163 million and an adjusted EBITDA margin of 23% to 25%.
  • Liquidity: The company has a credit facility with MidCap allowing borrowing up to $60 million, fully funded as of June 30, 2025.

4. Archetype and Conviction

Archetype: Growth Leader Fit Rationale: The company fits the Growth Leader archetype due to the acceleration in organic growth (7% vs. 3% prior year) and the successful transition from loss to profitability in Q1 2026. The business model exhibits high leverage to employment growth (recurring revenue scales with client headcount), and the backlog provides a visible revenue runway.

Valuation & Financial Spine:

  • Forward Consensus: FY1 EPS consensus is $0.85; FY2 EPS consensus is $1.05.
  • Margin Profile: Management guidance targets an adjusted EBITDA margin of 23-25% for 2026, indicating a high-margin SaaS business model.
  • Conviction Stack:
  • Thesis Strength: Moderate (Tactical/Setup-led, no macro tailwind).
  • Evidence Quality: High (Strong earnings transcript data, clear backlog visibility, positive earnings surprise).
  • Structural Quality: Moderate (ATR of 6.4% is "Very High," indicating elevated volatility which increases risk but also potential reward; setup is "Forming" rather than "Confirmed").
  • Setup Readiness: Partial (Forming coil requires a breakout to become actionable).
  • Rerating Potential: High, contingent on the confirmation of the breakout and the sustained delivery of the 23-25% EBITDA margin guidance.

ATR Context:

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

  • Fundamental: A miss on the full-year 2026 revenue guidance ($159M-$163M) or a failure to maintain the 23-25% EBITDA margin target.
  • Operational: A significant decline in the organic growth rate (below 5%) or a contraction in the backlog conversion rate.

What Would Strengthen the Case:

  • Fundamental: Management raising full-year guidance or providing evidence of accelerating backlog conversion rates.
  • Market: Continued resilience in the SMB client base despite broader economic headwinds.

Gaps in Evidence:

  • Breakout Confirmation: No data exists on whether the breakout has fired; the setup is explicitly "Forming."
  • Competitive Landscape: While the industry is described as competitive, specific market share data or competitive win/loss rates for 2026 are not detailed in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 2026 revenue growth of 23% YoY; Organic growth acceleration to 7% from 3% YoY; Transition from loss to $0.02 EPS in Q1 2026; Backlog of $85.6 million with 38% conversion expectation. Key risks: Very high ATR (6.4%) indicating elevated volatility and potential for sharp drawdowns; Setup is "Forming" and not yet confirmed as a breakout; No named secular thesis to provide macro tailwinds; Competitive HCM market with short product life cycles. Sizing hint: Position size should be reduced relative to a confirmed breakout setup due to the "Forming" status and "Very High" volatility bucket. Expected path: Management expects to convert 38% of backlog over 12 months and deliver 23-25% EBITDA margins; price likely to consolidate or test support before a potential breakout if fundamentals hold. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).

Loading chart...
Exhibit 1: ASUR daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for ASUR.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for ASUR.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: